| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/19/2003 | CN1398298A Non-endogenous, constitutively activated human G protein-coupled receptors |
| 02/19/2003 | CN1397790A Ultrasonic method and equipment for cleaning solid matrix after hybridization reaction |
| 02/19/2003 | CN1397649A Biochip base on 16S rDNA gene for diagnosing frequently encountered pathogenic bacteria |
| 02/19/2003 | CN1397648A Molecular biologic method for fastly diagnosing infections bronchitis virus of chicken |
| 02/19/2003 | CN1397640A Stem cell, and its preparing process and usage |
| 02/19/2003 | CN1101930C Cell ribonucleic acid Feulgen staning method |
| 02/19/2003 | CN1101854C G protein coupled receptor protein, prodn. and use thereof |
| 02/19/2003 | CN1101853C Method for amplitification of multiple gene/gene fragment |
| 02/19/2003 | CA2420065A1 Methods for indentifying specifically cleavable peptides and use of such peptide sequences |
| 02/18/2003 | US6521751 Recombinant nucleic acid sequences and methods for determining both genotoxicity and mutagenicity of a sample and the kinetics of the genotoxicity |
| 02/18/2003 | US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 02/18/2003 | US6521747 Haplotypes of the AGTR1 gene |
| 02/18/2003 | US6521739 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey |
| 02/18/2003 | US6521441 Staphylococcus aureus genes and polypeptides |
| 02/18/2003 | US6521437 Human sphingosine lyase polypeptides |
| 02/18/2003 | US6521436 Gene expression; drug screening for antiarthritic agents; bone disorders |
| 02/18/2003 | US6521432 Methods for enhancing the rate of modification of metastable bonds |
| 02/18/2003 | US6521428 Shot-gun sequencing and amplification without cloning |
| 02/18/2003 | US6521425 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521417 Incubating permeabilized cells expressing mutant kinase with radiolabeled analog; cytolysis, separation by sodium dodecyl sulfate polyacrylamide gel electrophoresis |
| 02/18/2003 | US6521415 Tandem immuno-assay for cancer |
| 02/18/2003 | US6521414 Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1 |
| 02/18/2003 | US6521413 Bioassay; monitoring cells for changes in ion channel activity |
| 02/18/2003 | US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders |
| 02/18/2003 | US6521410 Mutant of tissue factor pathway inhibitor, DNA sequence and use for detecting thrombotic disorders |
| 02/18/2003 | US6521409 Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| 02/18/2003 | US6521407 Methods for determining chemosensitivity of cancer cells based upon expression of negative and positive signal transduction factors |
| 02/18/2003 | US6521406 From Saccharopolyspora; genetic engineering |
| 02/18/2003 | US6521226 Administering Paraoxonase-1 (PON-1), an expressed protein that has hydrolase activity for organophosphates, and antioxidation activity for low-density lipoprotein (LDL) |
| 02/18/2003 | US6521225 AAV vectors |
| 02/18/2003 | US6521184 Apparatus for measuring a decomposable compound in solution |
| 02/18/2003 | US6521181 Microfabricated electrochemiluminescence cell for chemical reaction detection |
| 02/18/2003 | US6521110 Electrochemical cell |
| 02/18/2003 | CA2350860C Biosensor |
| 02/18/2003 | CA2215263C Methods for detecting colon cancer from stool samples |
| 02/18/2003 | CA2130072C Method of detecting a pathogen using a virus |
| 02/18/2003 | CA2075366C Immunologically active peptides or polypeptides from the parvovirus b19 |
| 02/18/2003 | CA2071904C Antibodies to ligand analogues and their utility in ligand-receptor assays |
| 02/18/2003 | CA2064331C Vascular endothelial cell growth factor c subunit |
| 02/15/2003 | CA2392309A1 Neuropeptide receptor and uses thereof |
| 02/15/2003 | CA2392305A1 Adrenic acid receptor and uses thereof |
| 02/14/2003 | WO2002014506A1 Method of estimating the genotype of fertility recovery locus to rice bt type male fertility cytoplasm |
| 02/14/2003 | CA2419460A1 Method of estimating the genotype of fertility recovery locus to rice bt type male fertility cytoplasm |
| 02/13/2003 | WO2003012676A2 Method for calculating a characteristic property of a molecule by correlation analysis |
| 02/13/2003 | WO2003012451A2 Methods for detecting of intermoleculair interactions using protein arrays |
| 02/13/2003 | WO2003012450A1 Diagnostic markers of liver dysfunction |
| 02/13/2003 | WO2003012447A2 Identification of living microorganisms, eukaryotic cells or organelles |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012439A2 Method for calculating a biological characteristic property of a molecule by correlation analysis |
| 02/13/2003 | WO2003012426A1 Lytic reagent composition for determination of nucleated red blood cells |
| 02/13/2003 | WO2003012422A1 Improved biosensor and method |
| 02/13/2003 | WO2003012410A1 Method for detecting at a solid support of complexing or hybridization between at least two basic molecules based on an amplified at the support |
| 02/13/2003 | WO2003012397A1 Microorganism-collecting chip, microorganism-collecting kit, method of quantifying microorganisms, specimen for confirming normal state of microorganism-quantifying apparatus and microorganism-quantifying apparatus |
| 02/13/2003 | WO2003012393A2 Method of detecting protease activity in a cell |
| 02/13/2003 | WO2003012390A2 Methods and devices for detecting hydrocarbons and petroleum products |
| 02/13/2003 | WO2003012389A2 Method for analysing macromolecules, analysis device and a method for producing an analysis device |
| 02/13/2003 | WO2003012147A1 Method for reusing standard blots and microarrays utilizing dna dendrimer technology |
| 02/13/2003 | WO2003012143A1 Genes and snps associated with eating disorders |
| 02/13/2003 | WO2003012142A1 Detection of nucleic acids by real-time pcr using chimeric rna-dna primers |
| 02/13/2003 | WO2003012141A1 Method of screening alzheimer’s disease-associated gene |
| 02/13/2003 | WO2003012140A1 Method of analyzing nucleic acid specifying gene showing change in expression dose in schizophrenia |
| 02/13/2003 | WO2003012139A2 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 02/13/2003 | WO2003012137A2 Methods for detecting parkinson's disease |
| 02/13/2003 | WO2003012136A2 Method to detect splice variants of the calcineurin gene |
| 02/13/2003 | WO2003012135A2 Method for the configuration of parallel nucleic acid analysis methods for sequence quantity classification |
| 02/13/2003 | WO2003012134A2 Paget disease of bone |
| 02/13/2003 | WO2003012133A2 Isp-1 and ctb-1 genes and uses thereof |
| 02/13/2003 | WO2003012132A2 Screening method for inhibitors of folate synthesis pathway enzymes |
| 02/13/2003 | WO2003012131A2 Assays for protease inhibitors, methods and means |
| 02/13/2003 | WO2003012130A1 Methods for generating antibiotic resistant microbes and novel antibiotics |
| 02/13/2003 | WO2003012129A2 Shikimate kinase from s. aureus for drug discovery |
| 02/13/2003 | WO2003012128A2 Method of detecting the activity of antibiotic which affects cell integrity |
| 02/13/2003 | WO2003012127A2 Assay for identifying inhibitors of hiv rt dimerization |
| 02/13/2003 | WO2003012126A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 02/13/2003 | WO2003012125A2 Mre11: modulation of cellular proliferation |
| 02/13/2003 | WO2003012124A2 Methods for immobilizing molecules to a solid phase and uses thereof |
| 02/13/2003 | WO2003012119A2 Nucleic acid amplification method |
| 02/13/2003 | WO2003012118A1 Complexity management of genomic dna |
| 02/13/2003 | WO2003012113A2 Inducible expression systems employing ppar transcriptional activators |
| 02/13/2003 | WO2003012108A2 Uses of a thyx polypeptide or a nucleic acid encoding such a polypeptide, in particular for screening anti-bacterial or anti-viral compounds |
| 02/13/2003 | WO2003012107A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 02/13/2003 | WO2003012105A2 Vegf isoform |
| 02/13/2003 | WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof |
| 02/13/2003 | WO2003012100A2 Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids |
| 02/13/2003 | WO2003012099A1 Chondroitin synthase |
| 02/13/2003 | WO2003012089A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
| 02/13/2003 | WO2003012086A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/13/2003 | WO2003012085A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 02/13/2003 | WO2003012078A2 Dendritic cells and the uses thereof in screening cellular targets and potential drugs |
| 02/13/2003 | WO2003012077A1 Method for preventing the adhesion of particles |
| 02/13/2003 | WO2003012070A2 Gene associated with bone disorders |
| 02/13/2003 | WO2003012068A2 Novel fusion proteins and assays for molecular binding |
| 02/13/2003 | WO2003012067A2 Expression profile of prostate cancer |
| 02/13/2003 | WO2003012066A2 Magnesium precipitate hot start method for molecular manipulation of nucleic acids |
| 02/13/2003 | WO2003012064A2 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 02/13/2003 | WO2003012062A2 Animal model with disrupted fgf14 gene |
| 02/13/2003 | WO2003012061A2 Methods and compositions relating to plasmacytoid dendritic cells |
| 02/13/2003 | WO2003012058A2 Media and methods for cultivation of microorganisms |
| 02/13/2003 | WO2003012046A2 Stk15 (stk6) gene polymorphism and methods of determining cancer risk |